Embedding Comprehensive Smoking Cessation Programs Into Community Clinics

NACompletedINTERVENTIONAL
Enrollment

406

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Smoking Cessation
Interventions
BEHAVIORAL

Intervention Arm

The smoking cessation intervention will include 1) a six-week, 60-75 minute weekly cognitive-behavioral therapy (CBT) smoking cessation counseling group; and 2) smoking cessation medication include varenicline (Chantix), bupropion (Zyban) and nicotine replacement therapy (NRT). Dispensing these medications will include a 15-minute medication management visit with a prescribing clinician. Clients will choose their own preferred treatment. The standard prescription for NRT will include a transdermal patch at a dose that approximates for current average mg of nicotine intake and nicotine gums or lozenges (in either 2 mg or 4 mg strengths). Prescription for varenicline will be 0.5 mg once daily for three days, then 0.5 mg twice daily for the next four days, then 1 mg twice daily thereafter. Absent any contraindications to the drugs listed above, bupropion (Zyban) 150mg will be offered and prescribed once daily for one week, following by bupropion 300 mg once daily thereafter.

Trial Locations (1)

90012

Los Angeles County Department of Health Services and Department of Mental Health Services, Los Angeles

All Listed Sponsors
collaborator

University of California

OTHER

lead

Friends Research Institute, Inc.

OTHER